Blogs

Pharmaceutical manufacturers rely on two distinct approaches to verify product and package quality: real-time monitoring during production and offline testing after production. Each plays a different role in a quality system, and choosing the right one, or the right combination, affects product safety, regulatory compliance, and production speed.

This blog breaks down how each approach works, where deterministic technologies like Vacuum Decay and HVLD fit in, and how manufacturers can build the right testing strategy for their products.

What Is Real-Time Monitoring, and How Does It Differ from Offline Testing?

Real-time monitoring captures and analyzes manufacturing process data as it happens, using sensors built directly into the production line. Offline testing, by contrast, pulls samples from a batch after production and analyzes them separately, away from the line.

Real-time monitoring is a core part of the FDA's Process Analytical Technology (PAT) framework. According to the FDA's PAT guidance for industry, PAT is "a system for designing, analyzing, and controlling manufacturing through timely measurements... of critical quality and performance attributes.

Offline testing works differently. A sample is removed from the batch, prepared, and tested in a lab or a dedicated inspection station. This includes methods like Vacuum Decay and HVLD leak testing, which confirm container closure integrity after a package is sealed.

What Are the Advantages and Limitations of Each Approach?

Real-time monitoring gives manufacturers continuous visibility and lets them catch deviations before they affect product quality. Offline testing gives manufacturers a deterministic, quantitative result on the finished package, which many methods still require for regulatory release.

Real-time monitoring reduces process variability and supports faster decision-making by tracking process conditions as they occur. Offline testing confirms package integrity directly, with a quantitative pass or fail result, though it depends on sampling and reports a defect only once that sample reaches the test.

Which Deterministic Technologies Support Offline Package Integrity Testing?

Vacuum Decay and HVLD are two of the most widely used deterministic technologies for confirming container closure integrity (CCI) after sealing, and both are referenced in USP <1207> guidance.

1.How Does Vacuum Decay Testing Work?

Vacuum Decay places a sealed package inside a test chamber and monitors the change in vacuum level over a set test time. A leak alters the vacuum reading, producing a quantitative, repeatable result in only a few seconds. The method follows ASTM F2338, a consensus standard recognized by the FDA, and can detect leaks in the single-digit micron range. It works on rigid, semi-rigid, and flexible packaging, including vials, syringes, and lyophilized products, and supports both laboratory testing and production-floor statistical process control.

2.How Does HVLD Testing Work?

HVLD scans a sealed, liquid-filled, non-conductive container with electrode probes. A defect such as a pinhole or crack changes the resistance and alters the current flow, which the system detects and localizes. HVLD works well on parenteral products, including pre-filled syringes, vials, and Blow-Fill-Seal containers, even with low-conductivity liquids. It requires no sample preparation and can run as an offline laboratory test or scale up to 100 percent inline inspection at production speed.

How Should Pharmaceutical Manufacturers Choose the Right Testing Strategy?

Most manufacturers combine both approaches to cover the full production cycle. Real-time monitoring supports process control during manufacturing, while offline deterministic testing confirms that each sealed package maintains closure integrity.

The right mix depends on the product:

• High-risk parenteral products, such as pre-filled syringes and biologics, typically need deterministic CCIT (Vacuum Decay or HVLD) alongside process monitoring, given the consequences of a compromised seal.
• Products with variable formulations or sensitive active ingredients benefit from continuous process monitoring to catch drift early.
• Manufacturers scaling up production often move offline methods like HVLD from lab-based testing to full inline inspection, combining the strengths of both approaches.

Frequently Asked Questions

1. Is real-time monitoring a replacement for offline package integrity testing.

No.Real-time monitoring tracks process conditions during manufacturing, while offline methods like Vacuum Decay and HVLD confirm the integrity of the sealed package itself. Most quality systems use both.

2. Which method does USP <1207> recommend for container closure integrity testing?

USP <1207> favors deterministic methods, including Vacuum Decay and HVLD, because they produce quantitative, repeatable results without relying on visual interpretation.

3. Can offline testing methods like HVLD also run inline?

Yes. HVLD systems can start as offline laboratory testing and scale up to 100 percent inline inspection at production speed as manufacturing volume grows.

As pharmaceutical manufacturing becomes increasingly automated, package inspection needs to keep pace with production demands. Container closure integrity testing (CCIT) and seal inspection are important parts of pharmaceutical packaging quality, particularly for products where package integrity is critical.

Automated inspection can help manufacturers increase testing capacity, reduce manual intervention, and create a more consistent and traceable inspection workflow.

PTI provides automated inspection solutions designed for different package formats and applications, including VeriPac LPX, E-Scan RTX, and Seal-Sensor PQX.

Why Is Automated Inspection Important for Pharmaceutical Manufacturing?

Manual inspection can require operators to handle samples, initiate tests, record results, and move products through different stages of the inspection process. As production volumes increase, these activities can limit testing capacity and introduce additional opportunities for operator-dependent variability.

Automated inspection can streamline these repetitive activities by combining testing with automated sample handling and result collection.

Depending on the application, automation can help manufacturers:

• Increase testing capacity
• Reduce manual sample handling
• Improve consistency
• Reduce operator-dependent variability
• Automate result collection
• Improve data traceability
• Support production-line inspection

The goal is not simply to make testing faster. It is to create a controlled and scalable inspection process that can support modern manufacturing requirements.

What Are PTI's Automated Inspection Solutions?

PTI's automated inspection portfolio includes three key solutions:

• VeriPac LPX – automated package and container closure integrity testing
• E-Scan RTX – automated CCI testing for parenteral products (pre-filled syringes)
• Seal-Sensor PQX – automated pouch seal inspection with built-in conveyor for easy handling

Each solution combines automation with a specific PTI inspection technology to address different package and application requirements.

How Does VeriPac LPX Support Automated CCIT?

VeriPac LPX is an automated package integrity testing solution based on PTI's Vacuum Decay technology. The system is designed to automate package integrity testing while reducing manual sample handling. For suitable applications, automated handling can move samples through testing and separate accepted and rejected products.

VeriPac LPX can support applications ranging from laboratory and batch release testing to production environments, helping manufacturers increase inspection capacity while maintaining quantitative, non-destructive testing.

How Does E-Scan RTX Support Automated CCI Testing?

E-Scan RTX is a fully automated container closure integrity testing solution designed for pre-filled syringes. The system uses PTI's HVLD technology together with automated robotic handling. Syringes can be automatically moved through the testing process and directed to the appropriate pass or reject location.

E-Scan RTX is designed for applications ranging from laboratory testing and batch release to high-volume production. Its automated workflow can reduce manual handling while providing rapid test results.

How Does Seal-Sensor PQX Support Automated Seal Inspection?

Seal-Sensor PQX is a fully automated pouch seal inspection and handling system. It uses PTI's Seal-Sensor Airborne Ultrasonic technology to inspect pouch seals online. The system incorporates automated handling and can identify defective seals and remove rejected pouches from the production process.

For manufacturers requiring high-volume pouch inspection, this provides an alternative to relying solely on manual or sampling-based seal inspection.

How Can Automated Inspection Support Batch Release?

Batch release involves the review of multiple quality attributes before a product can be released. Package integrity testing can become part of this workflow, particularly when large numbers of samples need to be tested and reviewed.

Automated inspection can support the process by:

• Increasing testing capacity
• Reducing manual handling
• Providing consistent test execution
• Generating clear test results
• Capturing test data electronically
• Improving traceability and data availability

PTI's VeriPac LPX and E-Scan RTX can support batch release applications where appropriate.

However, automated inspection does not independently determine whether a batch can be released. The final release decision remains subject to the manufacturer's quality system, procedures, acceptance criteria, and applicable regulatory requirements.

The benefit of automation is that it can make the inspection portion of the quality workflow more efficient and scalable.

What Should Manufacturers Consider When Selecting an Automated Inspection Solution?

The appropriate automated solution depends on the package, product, inspection objective, and production environment.

Manufacturers should consider:

• Package format: Size, shape, materials, and closure design can influence solution selection.
• Product characteristics: Product properties can affect the suitability of a particular inspection technology.
• Inspection objective: Requirements may include package leak detection, CCIT, or pouch seal inspection.
• Production requirements: Testing volume, throughput, handling, and line integration should be considered.
• Data requirements: Electronic data collection and traceability may be important for quality operations.
• Validation: The selected inspection method and automated system must be demonstrated to be suitable for the intended application.

No single automated inspection solution is appropriate for every package.

What Are the Benefits of Automated Inspection?

When appropriately implemented, automated inspection can provide manufacturers with:

• Increased inspection capacity
• Reduced manual handling
• More consistent testing
• Automated product handling
• Integration with production workflows
• Reduced operator-dependent variability

These capabilities can be particularly valuable for manufacturers managing high production volumes or seeking to reduce testing-related bottlenecks.

Conclusion

Automated inspection can help pharmaceutical manufacturers improve package testing efficiency by increasing inspection capacity, reducing manual intervention, and providing more consistent and traceable results.

By combining these automated solutions with PTI's inspection technologies, manufacturers can create scalable workflows for laboratory testing, batch release, at-line inspection, and production environments.

Automation does not replace quality controls or the manufacturer's batch release process. Instead, it provides a way to make package inspection more efficient while maintaining the testing and quality requirements of the specific application.

Frequently Asked Questions

1.What are PTI's automated inspection solutions?

PTI's key automated inspection solutions include VeriPac LPX, E-Scan RTX, and Seal-Sensor PQX. Each is designed for specific package inspection requirements.

2. What is VeriPac LPX?

VeriPac LPX is an automated package integrity testing solution based on PTI's Vacuum Decay technology.

3. What is E-Scan RTX?

E-Scan RTX is an automated CCI testing solution designed for pre-filled syringes using PTI's MicroCurrent HVLD technology.

Container Closure Integrity Testing (CCIT) is essential for verifying the integrity of pharmaceutical packaging. But the data generated during CCIT can provide more than a pass/fail result. When analyzed over time, it can help manufacturers identify changes in packaging-process performance and investigate potential issues before they become critical failures.

Why Is CCIT Data Important for Pharmaceutical Packaging Quality?

Container closure integrity plays an important role in protecting pharmaceutical products and maintaining package performance throughout the product lifecycle. Traditional CCIT testing establishes whether an individual package meets its defined integrity requirements.

However, individual test results provide only a snapshot of performance. When results from hundreds or thousands of tests are collected and analyzed over time, quality teams can identify patterns and trends that may not be apparent when reviewing results individually.

Changes in leak measurements, pressure or vacuum response, test repeatability, or other relevant parameters may indicate emerging process variation, even when individual packages continue to meet established acceptance criteria.

Predictive analytics does not replace validated CCIT acceptance criteria. Instead, it can provide an additional layer of process insight to support investigation and preventive action.

How Can Pharmaceutical Manufacturers Use CCIT Data for Predictive Analytics?

CCIT data becomes more valuable when test results are connected to relevant manufacturing information. Depending on the technology and application, this may include quantitative test results, pressure or vacuum response, test-cycle characteristics, package information, batch or lot numbers, production lines, equipment, maintenance events, and testing dates. This additional context allows quality teams to determine whether a change in CCIT results may be associated with a specific manufacturing event.

Predictive quality analysis can therefore help manufacturers:

• Identify gradual changes in packaging performance
• Detect unusual trends before specification limits are exceeded
• Support root-cause investigations
• Monitor consistency across production batches
• Support preventive maintenance decisions
• Strengthen process understanding and quality assurance

The effectiveness of this approach depends on consistent data collection, reliable test methods, and appropriate statistical analysis.

What CCIT Data Can PTI Technologies Provide for Predictive Analysis?

PTI's deterministic CCI technologies generate different types of quantitative information that may contribute to predictive quality analysis. The appropriate technology depends on the package, product, defect characteristics, sensitivity requirements, and validated application.

How Can VeriPac Vacuum Decay Data Support Predictive Quality?

PTI's VeriPac systems use vacuum decay technology to provide quantitative package integrity results. Depending on the system and application, the technology can be used with rigid, semi-rigid, and flexible pharmaceutical packaging.

For predictive quality analysis, historical vacuum-decay measurements can be evaluated for gradual shifts, increasing variation, or unusual patterns.

How Can HVLD Data Support Predictive Quality?

PTI's HVLD technology uses an electrical method to identify defects and conductive pathways in appropriate liquid-filled packaging applications.

Historical electrical-response data can potentially be analyzed to identify changes in package or seal performance over time. However, interpretation should account for the package material, product characteristics, test configuration, and validated method parameters.

A change in electrical response should be considered a signal for investigation rather than automatically classified as evidence of a package defect.

How Can Helium Leak Detection Data Support Predictive Quality?

Helium leak detection provides quantitative leak-rate information and can be particularly useful when highly sensitive leak measurements are required.

Instead of reviewing results only as pass or fail, manufacturers can analyze historical leak-rate measurements to determine whether results remain stable, whether variability is increasing, or whether measurements are changing in relation to manufacturing events.

This quantitative information can support statistical process monitoring when the test method and application are appropriate for such analysis.

How Can CCIT Trends Be Identified Before Failures Occur?

A packaging process does not necessarily move directly from stable performance to failure. Smaller changes may appear in the underlying measurements first.

For example, a process may show stable results initially, followed by a gradual measurement shift, increased variation, an abnormal trend, and eventually a result outside the established specification. Predictive analytics focuses on identifying these earlier changes.

Quality teams can monitor for patterns such as:

• Gradual changes in average measurements
• Increasing variation between test results
• Repeated unusual results associated with a particular batch or production line
• Changes following equipment adjustments or maintenance
• Trends associated with packaging-component changes

Depending on the dataset, manufacturers may use statistical process control (SPC), control charts, moving averages, trend analysis, anomaly detection, or regression analysis.

What Should Manufacturers Consider When Using CCIT Data for Predictive Analytics?

Predictive analytics is only as reliable as the data and methodology behind it. Manufacturers should consider several factors before using CCIT data for predictive quality management.

Historical comparisons should also be interpreted carefully when equipment, package configurations, test parameters, or analytical methods have changed.

What Is the Role of CCIT Data in the Future of Pharmaceutical Packaging Quality?

CCIT data has the potential to become more than a record of whether individual packages passed an integrity test. When collected consistently and interpreted in the right context, it can provide a broader view of packaging-process performance.

For manufacturers using PTI's deterministic technologies, quantitative CCIT results can contribute to this approach by providing measurable information that can be evaluated across batches, equipment, packaging configurations, and time.

The key is to use predictive analytics as a supporting quality tool, not as a replacement for validated testing or established acceptance criteria.

Conclusion: How Can CCIT Data Help Build a More Proactive Quality Strategy?

CCIT remains critical to pharmaceutical packaging quality, but its data can provide value beyond pass/fail decisions. By analyzing CCIT results over time and linking them with relevant manufacturing information, manufacturers can identify trends, investigate variation, and make more proactive quality decisions.

PTI’s VeriPac Vacuum Decay, HVLD, and helium leak detection technologies provide quantitative data that can support this approach within their validated applications. Ultimately, predictive CCIT analytics complements established quality controls by enabling earlier detection of changes, deeper process understanding, and continuous improvement in pharmaceutical packaging quality.

Frequently Asked Questions

1. Can CCIT data be used for predictive maintenance?

Yes. CCIT trends can support predictive maintenance when they are appropriately correlated with equipment and production data. A recurring change in test results following equipment wear, adjustment, or maintenance may warrant further investigation.

2. Which CCIT method is best for predictive analytics?

There is no single best CCIT method. The appropriate technology depends on the package, product, defect characteristics, sensitivity requirements, and validated application.

3. Does predictive analytics replace CCIT acceptance criteria?

No. Predictive analytics should complement established CCIT methods and acceptance criteria. It can identify trends and support investigations, but package acceptance should remain based on validated methods and predefined criteria.

3. Why is quantitative CCIT data useful?

Quantitative CCIT data allows manufacturers to analyze changes and variation over time rather than relying only on pass/fail results. When combined with relevant manufacturing information, it can provide additional insight into packaging-process performance.